Your browser doesn't support javascript.
loading
Early increase of plasma soluble VEGFR-2 is associated with clinical benefit from second-line treatment of paclitaxel and ramucirumab in advanced gastric cancer.
Fornaro, Lorenzo; Musettini, Gianna; Orlandi, Paola; Pecora, Irene; Vivaldi, Caterina; Banchi, Marta; Salani, Francesca; Fini, Elisabetta; Massa, Valentina; Catanese, Silvia; Cucchiara, Federico; Lencioni, Monica; Masi, Gianluca; Vasile, Enrico; Bocci, Guido.
Afiliación
  • Fornaro L; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Musettini G; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Orlandi P; Unit of Medical Oncology, Ospedale di Livorno Livorno, Italy.
  • Pecora I; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy.
  • Vivaldi C; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Banchi M; Unit of Medical Oncology, Ospedale della Misericordia Grosseto, Italy.
  • Salani F; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Fini E; Department of Translational Research and New Technologies in Medicine, University of Pisa Pisa, Italy.
  • Massa V; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy.
  • Catanese S; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Cucchiara F; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy.
  • Lencioni M; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Masi G; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
  • Vasile E; Department of Clinical and Experimental Medicine, University of Pisa Pisa, Italy.
  • Bocci G; Unit of Medical Oncology, Azienda Ospedaliero-Universitaria Pisana Pisa, Italy.
Am J Cancer Res ; 12(7): 3347-3356, 2022.
Article en En | MEDLINE | ID: mdl-35968330

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Prognostic_studies / Risk_factors_studies Idioma: En Revista: Am J Cancer Res Año: 2022 Tipo del documento: Article País de afiliación: Italia